Literature DB >> 12642065

Prostate cancer epidemiology.

Henrik Grönberg1.   

Abstract

Because more and more men are being diagnosed with prostate cancer worldwide, knowledge about and prevention of this disease is important. Epidemiological studies have provided some insight about the cause of prostate cancer in terms of diet and genetic factors. However, compared with other common cancers such as breast and lung cancer, the causes remain poorly understood. Several important issues could help in our understanding of this disease-the variation in incidence of prostate cancer between ethnic populations and the factors leading to familial clustering of the diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642065     DOI: 10.1016/S0140-6736(03)12713-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  305 in total

Review 1.  A review of African American-white differences in risk factors for cancer: prostate cancer.

Authors:  Irina Mordukhovich; Paul L Reiter; Danielle M Backes; Leila Family; Lauren E McCullough; Katie M O'Brien; Hilda Razzaghi; Andrew F Olshan
Journal:  Cancer Causes Control       Date:  2010-12-24       Impact factor: 2.506

2.  Prostate cancer survival in Trinidad: Is PSA a prognostic factor?

Authors:  Kameel Mungrue; Suresh Moonan; Maryam Mohammed; Saara Hyatali
Journal:  Can Urol Assoc J       Date:  2011-11-02       Impact factor: 1.862

Review 3.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

4.  Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Authors:  Punit Saraon; Natasha Musrap; Daniela Cretu; George S Karagiannis; Ihor Batruch; Chris Smith; Andrei P Drabovich; Dominique Trudel; Theodorus van der Kwast; Colm Morrissey; Keith A Jarvi; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

5.  Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.

Authors:  Sooryanarayana Varambally; Bharathi Laxman; Rohit Mehra; Qi Cao; Saravana M Dhanasekaran; Scott A Tomlins; Jill Granger; Adaikkalam Vellaichamy; Arun Sreekumar; Jianjun Yu; Wenjuan Gu; Ronglai Shen; Debashis Ghosh; Lorinda M Wright; Raleigh D Kladney; Rainer Kuefer; Mark A Rubin; Claus J Fimmel; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

6.  A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer.

Authors:  Andrew Rundle; Kathryn M Neckerman; Daniel Sheehan; Michelle Jankowski; Oleksandr N Kryvenko; Deliang Tang; Benjamin A Rybicki
Journal:  Cancer Causes Control       Date:  2012-12-08       Impact factor: 2.506

7.  Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status.

Authors:  Liyan Xue; Xueying Mao; Guoping Ren; Elzbieta Stankiewicz; Sakunthala C Kudahetti; Dongmei Lin; Luis Beltran; Daniel M Berney; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

8.  Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis.

Authors:  Jihong Wang; Yuemin Xu; Qiang Fu; Jianjun Yu; Zhong Chen; Zhangshun Liu; Chao Li; Hui Guo; Mingkai Xie
Journal:  Tumour Biol       Date:  2013-03-02

9.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  David Hatcher; Garrett Daniels; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

10.  Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.

Authors:  Lorella Bonaccorsi; Sara Marchiani; Monica Muratori; Gianni Forti; Elisabetta Baldi
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-16       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.